Cargando…

Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018

Detalles Bibliográficos
Autores principales: Herwaldt, Barbara L., Dougherty, Cindy P., Allen, Christopher K., Jolly, Julian P., Brown, Megan N., Yu, Patricia, Yu, Yon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065209/
https://www.ncbi.nlm.nih.gov/pubmed/30048425
http://dx.doi.org/10.15585/mmwr.mm6729a3
_version_ 1783342818837659648
author Herwaldt, Barbara L.
Dougherty, Cindy P.
Allen, Christopher K.
Jolly, Julian P.
Brown, Megan N.
Yu, Patricia
Yu, Yon
author_facet Herwaldt, Barbara L.
Dougherty, Cindy P.
Allen, Christopher K.
Jolly, Julian P.
Brown, Megan N.
Yu, Patricia
Yu, Yon
author_sort Herwaldt, Barbara L.
collection PubMed
description
format Online
Article
Text
id pubmed-6065209
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-60652092018-08-09 Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 Herwaldt, Barbara L. Dougherty, Cindy P. Allen, Christopher K. Jolly, Julian P. Brown, Megan N. Yu, Patricia Yu, Yon MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2018-07-27 /pmc/articles/PMC6065209/ /pubmed/30048425 http://dx.doi.org/10.15585/mmwr.mm6729a3 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Herwaldt, Barbara L.
Dougherty, Cindy P.
Allen, Christopher K.
Jolly, Julian P.
Brown, Megan N.
Yu, Patricia
Yu, Yon
Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018
title Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018
title_full Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018
title_fullStr Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018
title_full_unstemmed Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018
title_short Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018
title_sort characteristics of patients for whom benznidazole was released through the cdc-sponsored investigational new drug program for treatment of chagas disease — united states, 2011–2018
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065209/
https://www.ncbi.nlm.nih.gov/pubmed/30048425
http://dx.doi.org/10.15585/mmwr.mm6729a3
work_keys_str_mv AT herwaldtbarbaral characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018
AT doughertycindyp characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018
AT allenchristopherk characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018
AT jollyjulianp characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018
AT brownmegann characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018
AT yupatricia characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018
AT yuyon characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018